Dr. David Sinclair discusses the challenges of raising money for antiaging research due to the lack of profit motive in producing the inexpensive drug metformin. Despite relying on government funding and donors, progress is being made towards slowing down aging and measuring its effects. Title: Shifting Perspectives on Metformin Topics: Off-label use, Prescribing Summary: Matthew LaPlante and Dr. David Sinclair explore the growing acceptance among doctors to prescribe metformin off-label for its potential antiaging benefits. With education and evidence, physicians are becoming more open to considering metformin as a viable option, despite the risks involved.
